Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

718
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
718
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

786
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
786
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

714
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
714
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

449
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
449
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
Drug Therapy01:28

Drug Therapy

235
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
235

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pedicled chimeric superficial circumflex iliac artery perforator (SCIP) flap with external oblique fascia for vesicocutaneous bladder fistula repair: A case report and literature review on the utility of pedicled chimeric SCIP.

Microsurgery·2024
Same author

Evidence of Electron Heating by Alpha Particles in JET Deuterium-Tritium Plasmas.

Physical review letters·2023
Same author

The Development of Ethnic Group Perception.

The Journal of genetic psychology·2020
Same author

Cryo scanning transmission x-ray microscope optimized for spectrotomography.

The Review of scientific instruments·2018
Same author

Treatment and functional outcomes of complex tibial fractures in children and adolescents using the Ilizarov method.

The bone & joint journal·2018
Same author

The Relationship between "Pyrexia of Uncertain Origin" and Enteric Fever.

The Indian medical gazette·2017
Same journal

AI-Associated Psychotic Phenomena: Collect Before You Classify.

Acta psychiatrica Scandinavica·2026
Same journal

Developmental Trauma as a Prognostic Factor for Later Psychotic Disorder in an Adolescent Clinical Cohort: A 20-Year Follow Up Study.

Acta psychiatrica Scandinavica·2026
Same journal

The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis.

Acta psychiatrica Scandinavica·2026
Same journal

Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

Acta psychiatrica Scandinavica·2026
Same journal

Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

Acta psychiatrica Scandinavica·2026
Same journal

Leveraging Family Genetic Risk Scores to Understand the Etiology of Suicidal Behaviors and Their Associations With Psychiatric Disorders.

Acta psychiatrica Scandinavica·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice
04:44

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice

Published on: February 16, 2024

2.1K

Antipsychotics and QT prolongation.

D M Taylor1

  • 1South London and Maudsley NHS Trust, Denmark Hill, London. David.Taylor@slam.nhs.uk

Acta Psychiatrica Scandinavica
|January 22, 2003
PubMed
Summary
This summary is machine-generated.

Antipsychotic drugs may prolong the cardiac QTc interval, increasing the risk of dangerous heart rhythms and sudden death. Careful prescribing and monitoring are advised to mitigate these risks.

More Related Videos

Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

14.0K
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
08:38

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents

Published on: September 1, 2011

75.4K

Related Experiment Videos

Last Updated: Jan 11, 2026

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice
04:44

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice

Published on: February 16, 2024

2.1K
Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

14.0K
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
08:38

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents

Published on: September 1, 2011

75.4K

Area of Science:

  • Pharmacology
  • Cardiology
  • Psychiatry

Background:

  • Cardiac QT prolongation is a risk factor for dysrhythmia and sudden cardiac death.
  • Emerging data link antipsychotic drug use to increased cardiac mortality.
  • Many antipsychotics are associated with QTc prolongation.

Purpose of the Study:

  • To review existing literature on the relationship between antipsychotic medications and cardiac QT prolongation.
  • To assess the potential cardiac risks associated with antipsychotic drug use.

Main Methods:

  • Comprehensive literature searches were conducted in major biomedical databases (EMBASE, Medline, PsychLIT).
  • Reference sections of retrieved articles were meticulously reviewed for additional relevant studies.

Main Results:

  • The QTc interval, while challenging to measure precisely, is a recognized predictor of cardiac dysrhythmia and sudden death.
  • While direct causality is less clear, antipsychotic use is linked to elevated cardiac mortality.
  • Numerous antipsychotic agents have demonstrated a clear association with QTc interval prolongation.
  • Methodological limitations prevent definitive conclusions about antipsychotic-induced QTc prolongation risk.

Conclusions:

  • Current data are insufficient to quantify the precise risk of dysrhythmia or sudden death from antipsychotics.
  • Caution is warranted when prescribing antipsychotics.
  • Minimizing risk may involve low-dose prescribing, simple regimens, and avoiding drug interactions.
  • Electrocardiographic monitoring and specialist cardiology review may be beneficial in managing patient risk.